BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Berasain C, Goñi S, Castillo J, Latasa MU, Prieto J, Ávila MA. Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences. World J Gastroenterol 2010; 16(25): 3091-3102 [PMID: 20593494 DOI: 10.3748/wjg.v16.i25.3091]
URL: https://www.wjgnet.com/1007-9327/full/v16/i25/3091.htm
Number Citing Articles
1
Yu-Liang Lee, Jie-Wei Weng, Wen-Chin Chiang, Yi-Wen Lin, Ka-Lok Ng, Jeffrey Jing-Pha Tsai, Chi-Ying Huang. Investigating Cancer-related Proteins Specific Domain Interactions and Differential Protein Interactions Caused by Alternative Splicing2011 IEEE 11th International Conference on Bioinformatics and Bioengineering 2011; : 33 doi: 10.1109/BIBE.2011.12
2
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster. Alternative RNA Splicing in Fatty Liver DiseaseFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.613213
3
João Paulo Tavanez, Rafael Caetano, Cristina Branco, Inês Margarida Brito, Ana Miragaia‐Pereira, Tatiana Vassilevskaia, Ana Sofia Quina, Celso Cunha. Hepatitis delta virus interacts with splicing factor SF3B155 and alters pre‐mRNA splicing of cell cycle control genesThe FEBS Journal 2020; 287(17): 3719 doi: 10.1111/febs.15352
4
Yifan Li, Qiaozhen Zhu, Shuchang Zhou, Jiangtao Chen, Aoyu Du, Changjiang Qin. Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1202732
5
A. Fassina. ‘The map is not the territory’: FNA the map and liver the territoryCytopathology 2011; 22(5): 285 doi: 10.1111/j.1365-2303.2011.00928.x
6
Meraris Soto, Maria Reviejo, Ruba Al-Abdulla, Marta R. Romero, Rocio I.R. Macias, Loreto Boix, Jordi Bruix, Maria A. Serrano, Jose J.G. Marin. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(5): 165687 doi: 10.1016/j.bbadis.2020.165687
7
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factorsBMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
8
Yufeng Li, Junyu Xu, Yuting Lu, Hua Bian, Lin Yang, Honghong Wu, Xinwen Zhang, Beilei Zhang, Maoqian Xiong, Yafei Chang, Jie Tang, Fan Yang, Lei Zhao, Jing Li, Xin Gao, Mingfeng Xia, Minjia Tan, Jingya Li. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicingCell Metabolism 2021; 33(10): 2004 doi: 10.1016/j.cmet.2021.09.008
9
Jiayou Wang, Noah Kainrad, Hong Shen, Zhou Zhou, Paula Rote, Yanqiao Zhang, Laura E. Nagy, Jiashin Wu, Min You. Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed MiceThe American Journal of Pathology 2018; 188(8): 1807 doi: 10.1016/j.ajpath.2018.05.004
10
Olga Krivtsova, Anna Makarova, Natalia Lazarevich. Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinomaWorld Journal of Hepatology 2018; 10(10): 645-661 doi: 10.4254/wjh.v10.i10.645
11
Carmen Berasain, Maria Arechederra, Josepmaria Argemí, Maite G. Fernández-Barrena, Matías A. Avila. Loss of liver function in chronic liver disease: An identity crisisJournal of Hepatology 2023; 78(2): 401 doi: 10.1016/j.jhep.2022.09.001
12
Lu Zhang, Xiaoqiao Liu, Xuegong Zhang, Ronghua Chen. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasetsMolecular Genetics and Genomics 2016; 291(3): 1035 doi: 10.1007/s00438-015-1163-y
13
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinomaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
14
Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Dominique Wendum, Audrey Clapéron, Yves Chrétien, Colette Rey, Olivier Scatton, Olivier Soubrane, Filomena Conti, Françoise Praz, Chantal Housset, Olivier Rosmorduc, Christèle Desbois-Mouthon. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing FactorsCancer Research 2013; 73(13): 3974 doi: 10.1158/0008-5472.CAN-12-3824
15
Hualin Wang, Bouchra Lekbaby, Nadim Fares, Jeremy Augustin, Tarik Attout, Aurelie Schnuriger, Anne-Marie Cassard, Ganna Panasyuk, Gabriel Perlemuter, Ivan Bieche, Sophie Vacher, Janick Selves, Jean-Marie Péron, Brigitte Bancel, Philippe Merle, Dina Kremsdorf, Janet Hall, Isabelle Chemin, Patrick Soussan. Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcomeHepatology International 2019; 13(4): 454 doi: 10.1007/s12072-019-09950-7
16
Carla Rojo, María Gárate-Rascón, Miriam Recalde, Ane Álava, María Elizalde, María Azkona, Iratxe Aldabe, Elisabet Guruceaga, Amaya López-Pascual, M Ujue Latasa, Bruno Sangro, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesisJHEP Reports 2024; 6(8): 101118 doi: 10.1016/j.jhepr.2024.101118
17
Clémence Pinel, Barbara Prainsack, Christopher McKevitt. Markers as mediators: A review and synthesis of epigenetics literatureBioSocieties 2018; 13(1): 276 doi: 10.1057/s41292-017-0068-x
18
Julio Gutiérrez, Karel H. M. van Wely, Carlos Martínez-A. Hepatitis, testicular degeneration, and ataxia in DIDO3-deficient mice with altered mRNA processingCell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00804-8
19
Masaaki Takamura, Satoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, Yutaka Aoyagi. Involvement of liver-intestine cadherin in cancer progressionMedical Molecular Morphology 2013; 46(1): 1 doi: 10.1007/s00795-012-0003-y
20
María Elizalde, Raquel Urtasun, María Azkona, María U. Latasa, Saioa Goñi, Oihane García-Irigoyen, Iker Uriarte, Victor Segura, María Collantes, Mariana Di Scala, Amaia Lujambio, Jesús Prieto, Matías A. Ávila, Carmen Berasain. Splicing regulator SLU7 is essential for maintaining liver homeostasisJournal of Clinical Investigation 2014; 124(7): 2909 doi: 10.1172/JCI74382
21
Nicholas J. G. Webster. Alternative RNA Splicing in the Pathogenesis of Liver DiseaseFrontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00133
22
Hao Peng, Yifan Yang, Shandian Zhe, Jian Wang, Michael Gribskov, Yuan Qi, Alfonso Valencia. DEIsoM: a hierarchical Bayesian model for identifying differentially expressed isoforms using biological replicatesBioinformatics 2017; 33(19): 3018 doi: 10.1093/bioinformatics/btx357
23
Huang Li, Zhijia Wang, Xuexia Zhou, Yuanming Cheng, Zhiqin Xie, James L. Manley, Ying Feng. Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repressionProceedings of the National Academy of Sciences 2013; 110(29) doi: 10.1073/pnas.1310607110
24
Gui-Qi Zhu, Yu-Jie Zhou, Li-Xin Qiu, Biao Wang, Yi Yang, Wei-Ting Liao, Yi-Hong Luo, Ying-Hong Shi, Jian Zhou, Jia Fan, Zhi Dai. Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing dataCarcinogenesis 2019;  doi: 10.1093/carcin/bgz073
25
Shu Ly Lim, Carmela Ricciardelli, Martin K. Oehler, Izza M. D. De Arao Tan, Darryl Russell, Frank Grützner, Rajeev Samant. Overexpression of piRNA Pathway Genes in Epithelial Ovarian CancerPLoS ONE 2014; 9(6): e99687 doi: 10.1371/journal.pone.0099687
26
Carmen Berasain, Matías A. Avila. Regulation of hepatocyte identity and quiescenceCellular and Molecular Life Sciences 2015; 72(20): 3831 doi: 10.1007/s00018-015-1970-7
27
Belinda J. Petri, Kellianne M. Piell, Banrida Wahlang, Kimberly Z. Head, Eric C. Rouchka, Juw Won Park, Jae Yeon Hwang, Mayukh Banerjee, Matthew C. Cave, Carolyn M. Klinge. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver diseaseEnvironmental Toxicology and Pharmacology 2023; 103: 104260 doi: 10.1016/j.etap.2023.104260
28
María Gárate-Rascón, Miriam Recalde, Carla Rojo, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and DiseaseInternational Journal of Molecular Sciences 2022; 23(21): 13411 doi: 10.3390/ijms232113411
29
Carmen Berasain, María Elizalde, Raquel Urtasun, Josefa Castillo, Oihane García-Irigoyen, Iker Uriarte, Maria U Latasa, Jesús Prieto, Matías A Avila. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesisHepatic Oncology 2014; 1(2): 241 doi: 10.2217/hep.13.17
30
Marie-Pier Tremblay, Victoria E. S. Armero, Andréa Allaire, Simon Boudreault, Camille Martenon-Brodeur, Mathieu Durand, Elvy Lapointe, Philippe Thibault, Maude Tremblay-Létourneau, Jean-Pierre Perreault, Michelle S. Scott, Martin Bisaillon. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinomaBMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-3029-z
31
Anjali Kashyap, Greesham Tripathi, Avantika Tripathi, Rashmi Rao, Manju Kashyap, Anjali Bhat, Deepak Kumar, Anjali Rajhans, Pravindra Kumar, Darshan Shimoga Chandrashekar, Riaz Mahmood, Amjad Husain, Hatem Zayed, Alok Chandra Bharti, Manoj Kumar Kashyap. RNA splicing: a dual-edged sword for hepatocellular carcinomaMedical Oncology 2022; 39(11) doi: 10.1007/s12032-022-01726-8
32
Maria Reviejo, Meraris Soto, Elisa Lozano, Maitane Asensio, Olga Martínez-Augustin, Fermín Sánchez de Medina, Jose J.G. Marin. Impact of alternative splicing on mechanisms of resistance to anticancer drugsBiochemical Pharmacology 2021; 193: 114810 doi: 10.1016/j.bcp.2021.114810
33
Maria Gargani, Alessio Valentini, Lorraine Pariset. A novel point mutation within the EDA gene causes an exon dropping in mature RNA in Holstein Friesian cattle breed affected by X-linked anhidrotic ectodermal dysplasiaBMC Veterinary Research 2011; 7(1): 35 doi: 10.1186/1746-6148-7-35
34
Yoshito Tomimaru, Chelsea Q. Xu, Sarah B. Nambotin, Tao Yan, Jack R. Wands, Miran Kim. Loss of exon 4 in a human T‐cell factor‐4 isoform promotes hepatic tumourigenicityLiver International 2013; 33(10): 1536 doi: 10.1111/liv.12189
35
Tatsuhiro Shibata, Hiroyuki Aburatani. Exploration of liver cancer genomesNature Reviews Gastroenterology & Hepatology 2014; 11(6): 340 doi: 10.1038/nrgastro.2014.6
36
Jose J. G. Marin, Maria Reviejo, Meraris Soto, Elisa Lozano, Maitane Asensio, Sara Ortiz-Rivero, Carmen Berasain, Matias A. Avila, Elisa Herraez. Impact of Alternative Splicing Variants on Liver Cancer BiologyCancers 2021; 14(1): 18 doi: 10.3390/cancers14010018